| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $884.6M | +19.7% |
| Cost of Revenue | $190.4M | +10.7% |
| Gross Profit | $694.1M | +22.5% |
| R&D Expense | $214.8M | +11.4% |
| SG&A Expense | $112.9M | +9.6% |
| Operating Income | -$42.4M | +44.5% |
| Interest Expense | $12.0M | +0.1% |
| Pre-tax Income | -$22.4M | +54.7% |
| Income Tax | $3.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $338.8M | +12.2% |
| Accounts Receivable | $169.0M | +13.8% |
| Current Assets | $1.16B | +10.9% |
| Total Assets | $1.49B | +9.1% |
| Current Liabilities | $741.7M | +25.2% |
| Total Liabilities | $1.50B | +6.3% |
| Stockholders' Equity | -$5.4M | +87.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $140.1M | +59.7% |
| Capital Expenditures | $2.1M | +52.2% |
| Investing Cash Flow | -$35.0M | +22.8% |
| Financing Cash Flow | -$74.9M | -1211.8% |
| Free Cash Flow | $138.0M | +59.8% |
| -33.0% |
| Net Income | -$26.2M | +52.5% |
| EPS (Basic) | -$0.47 | +52.5% |
| EPS (Diluted) | -$0.47 | +52.5% |